Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boyle

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Breast (Edinburgh, Scotland)|January 8, 2014
Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)N McCarthy, F Boyle, N Zdenkowski, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 1, 1999
Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional ageJ Vanderhoof, S Gross, T Hegyi, et al.
European Journal of Cancer Care|August 5, 2017
The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancerB Vivat, T E Young, J Winstanley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2022
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE studyH S Rugo, J O'Shaughnessy, F Boyle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Overall survival with abemaciclib in early breast cancerS Johnston, M Martin, J O'Shaughnessy, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2020
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)F Cardoso, S Paluch-Shimon, E Senkus, et al.
Molecular Genetics and Metabolism Reports|August 14, 2018
Early feeding practices in infants with phenylketonuria across EuropeA Pinto, S Adams, K Ahring, et al.
Molecular Genetics and Metabolism Reports|February 2, 2019
Weaning practices in phenylketonuria vary between health professionals in EuropeA Pinto, S Adams, K Ahring, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Breast (Edinburgh, Scotland)|January 8, 2014
Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)N McCarthy, F Boyle, N Zdenkowski, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 1, 1999
Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional ageJ Vanderhoof, S Gross, T Hegyi, et al.
European Journal of Cancer Care|August 5, 2017
The international phase 4 validation study of the EORTC QLQ-SWB32: A stand-alone measure of spiritual well-being for people receiving palliative care for cancerB Vivat, T E Young, J Winstanley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2022
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE studyH S Rugo, J O'Shaughnessy, F Boyle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Overall survival with abemaciclib in early breast cancerS Johnston, M Martin, J O'Shaughnessy, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2020
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)F Cardoso, S Paluch-Shimon, E Senkus, et al.
Molecular Genetics and Metabolism Reports|August 14, 2018
Early feeding practices in infants with phenylketonuria across EuropeA Pinto, S Adams, K Ahring, et al.
Molecular Genetics and Metabolism Reports|February 2, 2019
Weaning practices in phenylketonuria vary between health professionals in EuropeA Pinto, S Adams, K Ahring, et al.
Pageof 16